insights_auto
Why is NEU up 2.27%?
Dive Deeperchevron_right
NEU:ASX
Neuren Pharmaceuticals Ltd
A$20.27
arrow_upward
+2.27%(+0.45) 1D
Sep 29, 4:10:07 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$19.80
High
A$20.60
Low
A$19.47
Mkt. cap
2.57B
Avg. vol.
483.08K
Volume
326.25K
Dividend
0.74%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
131.31
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$19.80
High
A$20.60
Low
A$19.47
Mkt. cap
2.57B
Avg. vol.
483.08K
Volume
326.25K
Dividend
0.74%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
131.31
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
TipRanks
·
10 hours ago
Neuren’s Rett Drug Trofinetide Gains U.S. Patent Extension to 2041
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com